The first case report of the treatment of transplant coronary artery disease with dextran sulfate adsorption lipid apheresis

Therapeutic Apheresis and Dialysis

Volumn 14, Issue 2, 2010, Pages 218-221

  Sosland, Rachel P ^a   Gollub, Steven B ^a   Wilson, David B ^a   Moriarty, Patrick M ^a  

^a UNIVERSITY OF KANSAS HOSPITAL   (United States)

Author keywords

Adenosine thallium; Coronary artery disease; Heart transplant; Low density lipoprotein apheresis; Vasculopathy

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; ATENOLOL; CREATINE; CREATINE KINASE; CYCLOSPORIN; DEXTRAN SULFATE; FIBRINOGEN; HYDROCHLOROTHIAZIDE; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; ROSUVASTATIN; THALLIUM;

ADULT; APHERESIS; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PARAMETERS; CASE REPORT; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG WITHDRAWAL; FAMILIAL HYPERLIPEMIA; FOLLOW UP; HEART EJECTION FRACTION; HEART LEFT VENTRICLE VOLUME; HEART TRANSPLANTATION; HUMAN; ISCHEMIA; LIPID APHERESIS; LOW DRUG DOSE; MALE; MYALGIA; PRIORITY JOURNAL; PULMONARY TO MYOCARDIAL COUNT RATIO; RISK FACTOR; SIDE EFFECT;

BLOOD COMPONENT REMOVAL; CHOLESTEROL; CORONARY DISEASE; DEXTRAN SULFATE; HEART TRANSPLANTATION; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEIN(A); LIPOPROTEINS, LDL; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 77950208768     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2009.00749.x     Document Type: Article

References (9)

1. Moriarty PLD. L- apheresis therapy: current therapeutic practice and potential future use. Future Lipidol 2006 1 : 299 308.
2. Wenke K. Management of hyperlipidemia associated with heart transplantation. Drugs 2004 64 : 1053 1068.
3. Babir M, Kushwaha S, Hunt B et al. Lipoprotein(a) and accelerated coronary artery disease in cardiac transplant recipients. Lancet 1992 340 : 1500 1502.
4. Thiery B, Meiser K, Wenke C. Heparin-Induced Extracorporeal Low-Density-Lipoprotein Plasmapheresis (HELP) and its use in heart transplant patients with hypercholesterolemia. Transplant Proc 1995 27 : 1950 1953.
5. Dzemeshkevich S, Ragimov A, Mikhaylov Y et al. Plasmapheresis in the treatment of post-transplant cardiomyopathy. Artif Organs 1998 22 : 197 202.
6. Park JW, Merz M, Braun P. Regression of transplant coronary artery disease during chronic low-density lipoprotein-apheresis. J Heart Lung Transplant 1997 16 : 290 297.
7. Matschke K, Mrowietz C, Sternitzky R, Jung F, Park JW. Effect of LDL apheresis on oxygen tension in skeletal muscle in patients with cardiac allograft vasculopathy and severe lipid disorder. Clin Hemorheol Microcirc 2004 30 : 263 271.
8. Jaeger BR, Meiser B, Nagel D et al. Aggressive lowering of fibrinogen and cholesterol in the prevention of graft vessel disease after heart transplantation. Circulation 1997 96 : II-8.
9. Jaeger BR, Schirmer J, Thiery J et al. Coronary risk factor management for the prevention and treatment of graft vessel disease in heart transplant patients. Ther Apher 1999 3 : 214 218.